Published in Nat Rev Rheumatol on March 30, 2010
MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J Clin Invest (2012) 2.24
ETS-related gene (ERG) controls endothelial cell permeability via transcriptional regulation of the claudin 5 (CLDN5) gene. J Biol Chem (2012) 1.11
Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center. Clin Rheumatol (2011) 0.90
Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade. Clin Rheumatol (2014) 0.86
Contractile, but not endothelial, dysfunction in early inflammatory arthritis: a possible role for matrix metalloproteinase-9. Br J Pharmacol (2012) 0.85
Inflammation and hypertension in rheumatoid arthritis. J Rheumatol (2013) 0.84
What is the future of targeted therapy in rheumatology: biologics or small molecules? BMC Med (2014) 0.83
Visualization of endothelial barrier damage prior to formation of atherosclerotic plaques. Histochem Cell Biol (2017) 0.79
Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases. Int J Mol Sci (2012) 0.78
Determination of the diagnostic values of asymmetric dimethylarginine as an indicator for evaluation of the endothelial dysfunction in patients with rheumatoid arthritis. Arthritis (2013) 0.78
Decreased heart rate variability in patients with psoriatic arthritis. Clin Rheumatol (2012) 0.78
Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis. BMC Med (2012) 0.78
Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study. Arthritis Care Res (Hoboken) (2016) 0.77
Effect of mesenchymal precursor cells on the systemic inflammatory response and endothelial dysfunction in an ovine model of collagen-induced arthritis. PLoS One (2015) 0.77
RhoB controls endothelial barrier recovery by inhibiting Rac1 trafficking to the cell border. J Cell Biol (2016) 0.76
Aberrant glycosylation of plasma proteins in severe preeclampsia promotes monocyte adhesion. Reprod Sci (2013) 0.75
The suppression of bromodomain and extra-terminal domain inhibits vascular inflammation by blocking NF-κB and MAPK activation. Br J Pharmacol (2016) 0.75
Collagen-induced arthritis increases inducible nitric oxide synthase not only in aorta but also in the cardiac and renal microcirculation of mice. Clin Exp Immunol (2015) 0.75
Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation. Arthritis Res Ther (2017) 0.75
Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis. Intern Emerg Med (2017) 0.75
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet (2002) 9.66
Prognostic value of coronary vascular endothelial dysfunction. Circulation (2002) 7.68
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62
Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med (1986) 6.05
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis (2009) 5.82
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum (2005) 5.31
Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol (1995) 5.26
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum (2008) 4.20
Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol (2007) 4.13
Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol (2003) 3.87
Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum (2002) 3.53
Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis (2006) 3.48
Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol (2006) 3.18
Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation (2006) 2.70
von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J (2002) 2.66
Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum (2002) 2.62
All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol (2003) 2.52
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis (2007) 2.46
Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation (2002) 2.45
Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody. Arthritis Rheum (2004) 2.32
Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum (2003) 2.29
HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum (2007) 2.28
Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) (2007) 2.22
Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation (1999) 2.14
Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation (1999) 2.08
High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy. Eur J Clin Invest (2008) 2.05
Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum (2005) 2.02
Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Intern Med (2005) 1.98
Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis. Arthritis Rheum (2004) 1.94
Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis. Circulation (2008) 1.85
Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy. Arthritis Rheum (2008) 1.78
Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum (2007) 1.78
Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med (2005) 1.77
High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol (2005) 1.72
Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol (1999) 1.72
Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity. Atherosclerosis (2003) 1.71
Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med (2008) 1.70
Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum (2007) 1.67
Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum (2008) 1.63
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63
The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty. Circulation (1997) 1.61
Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis (2006) 1.56
Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis. J Hypertens (2007) 1.55
Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis (2004) 1.53
Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study. Arthritis Rheum (2008) 1.51
Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med (2003) 1.45
Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardiol (2007) 1.44
Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol (2002) 1.40
Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum (2002) 1.37
Impaired skin microvascular function in children, adolescents, and young adults with type 1 diabetes. Diabetes Care (2000) 1.36
Hypertension in rheumatoid arthritis. Rheumatology (Oxford) (2008) 1.36
HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med (2003) 1.36
Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med (2008) 1.33
Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol (2008) 1.31
Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arterioscler Thromb Vasc Biol (2009) 1.30
Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. J Rheumatol (2008) 1.29
Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest (2003) 1.28
Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation. Am J Cardiol (2006) 1.28
Mortality in rheumatoid arthritis. Semin Arthritis Rheum (1995) 1.26
Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis. Circ J (2009) 1.25
Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand J Rheumatol (2000) 1.24
Relationship between peripheral and coronary function using laser Doppler imaging and transthoracic echocardiography. Clin Sci (Lond) (2008) 1.21
Short-term adalimumab therapy improves endo-thelial function in patients with rheumatoid arthritis refractory to infliximab. Clin Exp Rheumatol (2006) 1.20
Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum (1997) 1.20
Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int (2004) 1.19
Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum (2004) 1.14
Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci (2006) 1.09
What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology. Ann Rheum Dis (2007) 1.09
Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology (Oxford) (2002) 1.07
Cardiovascular risk in rheumatoid arthritis. Autoimmun Rev (2009) 1.06
Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year followup study. J Rheumatol (2000) 1.03
Relative risk of cardiovascular events in patients with rheumatoid arthritis. Am J Cardiol (2002) 1.01
Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients. Scand J Rheumatol (2009) 1.00
Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA (1999) 1.00
TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. Clin Rheumatol (2007) 0.97
Assessment of microvascular endothelial function in human skin. Clin Sci (Lond) (2001) 0.96
Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther (2009) 0.96
Inducible nitric oxide synthase activity is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunction. Int J Cardiol (2008) 0.95
C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction. Cardiovasc Res (2009) 0.92
C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology (Oxford) (2008) 0.91
Endothelial progenitor cells and rheumatic disorders. Joint Bone Spine (2008) 0.91
Impaired microvascular function in normal children: effects of adiposity and poor glucose handling. J Physiol (2003) 0.89
Cellular adhesion molecules and cardiovascular disease. Part II. Their association with conventional and emerging risk factors, acute coronary events and cardiovascular risk prediction. Intern Med J (2003) 0.89
Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis. Rheumatol Int (2006) 0.89
Etanercept improves inflammation-associated arterial stiffness in rheumatoid arthritis. Rheumatology (Oxford) (2009) 0.89
Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritis. Atherosclerosis (2006) 0.88
Pioglitazone improves endothelial function in non-diabetic patients with coronary artery disease. Cardiology (2006) 0.88
A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Blood Coagul Fibrinolysis (2003) 0.86
Risk factors associated with different stages of atherosclerosis in Colombian patients with rheumatoid arthritis. Semin Arthritis Rheum (2008) 0.86
Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis. Scand J Rheumatol (2007) 0.86
Reducing the cardiovascular disease burden in rheumatoid arthritis. Med J Aust (2006) 0.83
Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy. J Rheumatol (2010) 0.83
Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis. Scand J Rheumatol (2009) 0.82
Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon. Circulation (1994) 0.81
Modulation of arterial reactivity using amlodipine and atorvastatin measured by ultrasound examination (MARGAUX). Atherosclerosis (2007) 0.81
Macrovascular disease in systemic sclerosis: the tip of an iceberg? Rheumatology (Oxford) (2008) 0.79
Atherogenesis and inflammation--was Virchow right? Nephrol Dial Transplant (2007) 0.79
Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis. Ann Rheum Dis (1993) 0.78
Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level. Clin Rheumatol (2004) 0.78
Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation (2002) 3.72
Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops. Hypertension (2005) 2.92
Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. J Am Coll Cardiol (2011) 1.88
Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med (2005) 1.64
Chemical synthesis and microvascular effects of new nitric oxide donors in humans. Clin Sci (Lond) (2003) 1.39
Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med (2008) 1.33
Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication. Circulation (2011) 1.25
Relationship between peripheral and coronary function using laser Doppler imaging and transthoracic echocardiography. Clin Sci (Lond) (2008) 1.21
Study protocol for BeWEL: the impact of a BodyWEight and physicaL activity intervention on adults at risk of developing colorectal adenomas. BMC Public Health (2011) 1.15
Biochemical and vascular aspects of pediatric chronic fatigue syndrome. Arch Pediatr Adolesc Med (2010) 1.07
Allopurinol treatment reduces arterial wave reflection in stroke survivors. Cardiovasc Ther (2008) 0.99
Circadian variation in vascular tone and endothelial cell function in normal males. Clin Sci (Lond) (2002) 0.97
The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects. Cardiovasc Res (2003) 0.97
The effect of adjuvant epinephrine concentration on the vasoactivity of the local anesthetics bupivacaine and levobupivacaine in human skin. Reg Anesth Pain Med (2004) 0.92
Optimization of the contrast dose and injection rates in whole-body MR angiography at 3.0T. J Magn Reson Imaging (2009) 0.92
Impaired microvascular function in normal children: effects of adiposity and poor glucose handling. J Physiol (2003) 0.89
Influence of vehicle resistance on transdermal iontophoretic delivery of acetylcholine and sodium nitroprusside in humans. J Appl Physiol (1985) (2004) 0.89
Etanercept improves inflammation-associated arterial stiffness in rheumatoid arthritis. Rheumatology (Oxford) (2009) 0.89
Effects of vitamin D supplementation on markers of vascular function after myocardial infarction--a randomised controlled trial. Int J Cardiol (2012) 0.88
Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK--a randomised controlled trial. Atherosclerosis (2013) 0.88
Dark chocolate inhibits platelet aggregation in healthy volunteers. Platelets (2003) 0.88
Spiral laminar flow in the abdominal aorta: a predictor of renal impairment deterioration in patients with renal artery stenosis? Nephrol Dial Transplant (2004) 0.86
B-type natriuretic peptide is an independent predictor of endothelial function in man. Clin Sci (Lond) (2012) 0.85
Low-grade inflammation and arterial wave reflection in patients with chronic fatigue syndrome. Clin Sci (Lond) (2008) 0.85
The specificity of the CDC-1994 criteria for chronic fatigue syndrome: comparison of health status in three groups of patients who fulfill the criteria. Ann Epidemiol (2004) 0.85
Peripheral cholinergic function in humans with chronic fatigue syndrome, Gulf War syndrome and with illness following organophosphate exposure. Clin Sci (Lond) (2004) 0.85
Two-dimensional flow quantitative MRI of aortic arch blood flow patterns: Effect of age, sex, and presence of carotid atheromatous disease on prevalence of spiral blood flow. J Magn Reson Imaging (2003) 0.85
The association between serum urate levels and arterial stiffness/endothelial function in stroke survivors. Atherosclerosis (2008) 0.85
Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy. J Rheumatol (2010) 0.83
The use of Ginkgo biloba in Raynaud's disease: a double-blind placebo-controlled trial. Vasc Med (2002) 0.79
The beneficial effects of breastfeeding on microvascular function in 11- to 14-year-old children. Vasc Med (2009) 0.79
Is chronic fatigue syndrome associated with platelet activation? Blood Coagul Fibrinolysis (2006) 0.79
A feasibility study of a personalised lifestyle programme (HealthForce) for individuals who have participated in cardiovascular risk screening. Prev Med (2011) 0.79
Association of common variation in glutathione S-transferase genes with premature development of cardiovascular disease in patients with systemic sclerosis. Arthritis Rheum (2003) 0.79
Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology. Cardiovasc Ther (2009) 0.79
Left ventricular hypertrophy is present in one-half of newly-diagnosed peripheral arterial disease patients. J Hypertens (2007) 0.78
Relationship between maternal arterial wave reflection, microvascular function and fetal growth in normal pregnancy. Microcirculation (2010) 0.78
Dietary lipids and vascular function: UK Food Standards Agency workshop report. Br J Nutr (2004) 0.78
Large and small artery endothelial dysfunction in chronic fatigue syndrome. Int J Cardiol (2011) 0.77
Prolonged acetylcholine-induced vasodilatation in the peripheral microcirculation of patients with chronic fatigue syndrome. Clin Physiol Funct Imaging (2003) 0.77
Spiral laminar flow prosthetic bypass graft: medium-term results from a first-in-man structured registry study. Ann Vasc Surg (2012) 0.77
Vasoactive properties of lignocaine administered by iontophoresis in human skin. Clin Sci (Lond) (2003) 0.75
Transcutaneous Electrical Nerve Stimulation Improves Walking Performance in Patients With Intermittent Claudication. J Cardiovasc Nurs (2016) 0.75
Reply: The Enigma of Left Ventricular Non-Compaction. J Am Coll Cardiol (2017) 0.75
A focus on risk factor management. Vasc Med (2004) 0.75